Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
Centre Oscar Lambret
Centre Oscar Lambret
National Institutes of Health Clinical Center (CC)
Children's Hospital Los Angeles
Actuate Therapeutics Inc.
University Health Network, Toronto
SynerGene Therapeutics, Inc.
Immatics US, Inc.
Adaptimmune
Adaptimmune
Adaptimmune
Gilead Sciences
Genocea Biosciences, Inc.
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aduro Biotech, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
ImmunoVaccine Technologies, Inc. (IMV Inc.)
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center